Investing in our future

Delivering high-quality medicines to patients takes cutting-edge technology, innovation, and dedicated people. At our pharmaceutical facility in Boronia, Victoria, we are joining these elements through strategic investment and patient focus.

To recognise our progress and discuss the future of the pharmaceutical industry in Victoria, the Hon. Wade Noonan, Minister for Industry and Employment recently visited the GSK facility in Boronia. While promoting the launch of the State of the Sector Medical Technologies and Pharmaceuticals 2017 report, Minister Noonan toured the vaccines pilot plant, built to trial a world-first commercial supply of a heat-sensitive vaccine filled in state-of-the-art Blow-Fill-Seal (BFS) technology*.

Hon. Wade Noonan, Minister for Industry and Employment comments on GSK's part in the Victorian medical technologies and pharmaceuticals sector.

During his visit, the minister said, “We’ve experienced a substantial growth in this sector in Victoria … a doubling of exports since 2011. GSK themselves are an integral part of the Victorian [medical technologies and pharmaceuticals] sector … they are such a vital component , and what we’re here really looking at today is the investments they’ve made.

The Boronia facility is located in Australia’s biotech hub of Greater Melbourne, and GSK is proud to be collaborating with other organisations and education institutions to push the limits of innovation in the pharmaceutical industry in Victoria.

Boronia site director, Dave Morley, said, “Minister Noonan’s visit was a fantastic opportunity to showcase how GSK Boronia continues evolve and innovate to remain at the forefront of the Advanced Manufacturing sector”


*BFS is a sterile method of blowing plastic into moulds creating a container, filling the moulded container with product, and sealing the container in one continuous process.

Related tags

Back to top